BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 19, 2026
See today's BioWorld
Home
» Looking to Raise $49M, ArQule Expands Public Stock Offering
To read the full story,
subscribe
or
sign in
.
Looking to Raise $49M, ArQule Expands Public Stock Offering
April 12, 2012
By
Mari Serebrov
On its way to the public trough, ArQule Inc. decided to go for a bigger portion, opting to increase its underwritten offering to 7.15 million shares priced at $7.30 per share.
BioWorld